8 - A Conversation on HCV Elimination

Thursday, October 20, 2022

8:00 AM – 9:00 AM US ET

Location: 150 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Michael Melia, MD

ID Fellowship Program Director
Johns Hopkins University
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose
Dawn Fishbein, MD, MS (she/her/hers)

Scientific Director, VIral Hepatitis Research
Research-MCRC
MedStar Health Research Institute
Washington, DC, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Faculty(s)

John Ward, MD

Director, Global Hepatitis Elimination
The Task Force for Global Health
Decatur, GA, United States

Disclosure(s): Abbott, Abb-Vie, Merck, Gilead, Pharco, Roche, Siemens ,: General funding to the Task Force for Global Healht for support of the Coalition for Global Hepatitis Elimination Global Fund for (Ongoing)

Slides
Shruti Mehta, PhD, MPH

Professor
Epidemiology
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Michael T. Melia, MD: No financial relationships to disclose

John Ward, MD: Abbott, Abb-Vie, Merck, Gilead, Pharco, Roche, Siemens ,: General funding to the Task Force for Global Healht for support of the Coalition for Global Hepatitis Elimination Global Fund for (Ongoing)

Shruti Mehta, PhD, MPH: No financial relationships to disclose

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the current status of HCV elimination efforts within the United States;
describe the status of HCV elimination efforts from the perspective of people who use drugs;
discuss innovations and strategies to help reach global HCV elimination goals

Presentations:

8:00 AM – 8:30 AM US ET

Perspectives From the United States (and Beyond)
Speaker: John Ward, MD – The Task Force for Global Health
8:30 AM – 9:00 AM US ET

Perspectives From the Lens of People Who Use Drugs
Speaker: Shruti Mehta, PhD, MPH – Johns Hopkins Bloomberg School of Public Health